Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion type Assertion NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_head.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion wasGeneratedBy ECO_0000203 NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion wasDerivedFrom befree-20150227 NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion SIO_000772 11714450 NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion evidence source_evidence_literature NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.
- NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_assertion description "[Paclitaxel and SN-38 (an active metabolite of irinotecan (CPT-11)) are two drugs that are effective in patients with DDP-resistant ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925900.RA14Ews8HI4E4HUvNwpxvRa3HvEVHoj6a4pXe6vrasm40130_provenance.